INS and metabolic dysfunction-associated steatotic liver disease: This finding holds particular significance because, although it is well established that weight loss effectively reduces liver fat accumulation and enhances glycaemic control and insulin sensitivity in NAFLD patients (Younossi et al., 2021), the reality is that only a few individuals manage to achieve the required 10% minimum weight loss (Romero‐Gómez et al., 2017).